For older people and frail people, the long-term benefit of medicines reduces and the potential for harm from adverse effects increases. When the benefit–risk balance changes in this way, medicine review and optimisation are important to simplify the therapeutic regimen, reduce inappropriate medicines and minimise risks. In this article, pharmacist prescriber Linda Bryant uses two case studies to illustrate important considerations during medicine reviews
‘Ideally placed’ to manage COVID-19
Wednesday 16 February 2022, 02:40 AM

Matire Harwood says taking care of COVID-19 patients in their homes can be done to a high standard [Greg Bowker Visuals]
“You have to make it work for you. So we did it our own way, but made sure we monitored it.”
With last year’s shift from Managed Isolation and Qu
Kia ora and welcome to New Zealand Doctor Rata Aotearoa
Not a subscriber? Unlock this article by subscribing here.
References
Harwood M, Te Paa S, Kearns N, et al. An audit of a marae-based health centre management of COVID-19 community cases in South Auckland. NZ Med J 2022 (open access);135,1549:120–128.